{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:18:02Z","timestamp":1783167482435,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cgh.2026.04.022","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:21:11Z","timestamp":1779294071000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatic Steatosis Is Associated With Increased Cardiovascular Risk Through Adverse Coronary Plaque Composition"],"prefix":"10.1016","author":[{"given":"Jan M.","family":"Brendel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mayrhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra M.","family":"Kerkovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rton","family":"Kolossv\u00e1ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ers\u00f6zl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Alhanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svati H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini M.","family":"Meyersohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maros","family":"Ferencik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Lamon-Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela S.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2466-4827","authenticated-orcid":false,"given":"Borek","family":"Foldyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.04.022_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","article-title":"Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017\u20132020","volume":"22","author":"Kalligeros","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.04.022_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.04.022_bib3","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.04.022_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jhep.2015.02.045","article-title":"Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study","volume":"63","author":"Mellinger","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.04.022_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cgh.2026.04.022_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.04.022_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.04.022_bib8","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.cgh.2020.07.030","article-title":"Association of hepatic steatosis with major adverse cardiovascular events, independent of coronary artery disease","volume":"19","author":"Meyersohn","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.04.022_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.04.022_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jcct.2025.05.003","article-title":"Plaque quantification from coronary computed tomography angiography in predicting cardiovascular events: a systematic review and meta-analysis","volume":"19","author":"Bell","year":"2025","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.cgh.2026.04.022_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcct.2020.11.002","article-title":"Society of cardiovascular computed tomography \/ North American Society of cardiovascular imaging \u2013 expert consensus document on coronary CT imaging of atherosclerotic plaque","volume":"15","author":"Shaw","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.cgh.2026.04.022_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jcmg.2023.02.002","article-title":"Advances in coronary computed tomographic angiographic imaging of atherosclerosis for risk stratification and preventive care","volume":"16","author":"Bienstock","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cgh.2026.04.022_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ehjci\/jeaa228","article-title":"Quantified coronary total plaque volume from computed tomography angiography provides superior 10-year risk stratification","volume":"22","author":"Deseive","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cgh.2026.04.022_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcct.2021.07.001","article-title":"Quantitative assessment of atherosclerotic plaque, recent progress and current limitations","volume":"16","author":"Williams","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.cgh.2026.04.022_bib15","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2026.04.022_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamacardio.2017.4973","article-title":"Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain","volume":"3","author":"Ferencik","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cgh.2026.04.022_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcmg.2023.05.020","article-title":"AI-Guided quantitative plaque staging predicts long-term cardiovascular outcomes in patients at risk for atherosclerotic CVD","volume":"17","author":"Nurmohamed","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cgh.2026.04.022_bib18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jcmg.2025.06.007","article-title":"Sex-specific prognostic value of quantifying coronary plaque in patients with stable chest pain: insights from the PROMISE trial","volume":"18","author":"Brendel","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cgh.2026.04.022_bib19","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.210260","article-title":"Hepatosteatosis and atherosclerotic plaque at coronary CT angiography","volume":"4","author":"Carter","year":"2022","journal-title":"Radiol Cardiothorac Imaging"},{"key":"10.1016\/j.cgh.2026.04.022_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jacc.2021.10.035","article-title":"Coronary atherosclerotic plaque regression: JACC state-of-the-art review","volume":"79","author":"Dawson","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2026.04.022_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ahj.2014.03.003","article-title":"PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial","volume":"167","author":"Douglas","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.cgh.2026.04.022_bib22","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1415516","article-title":"Outcomes of anatomical versus functional testing for coronary artery disease","volume":"372","author":"Douglas","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2026.04.022_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2214\/AJR.09.2590","article-title":"Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT","volume":"194","author":"Boyce","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2026.04.022_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.09090769","article-title":"Presence of coronary plaques in patients with nonalcoholic fatty liver disease","volume":"254","author":"Assy","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2026.04.022_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jcct.2013.08.011","article-title":"Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"Zeb","year":"2013","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.cgh.2026.04.022_bib26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1148\/radiol.10101233","article-title":"Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT","volume":"258","author":"Park","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2026.04.022_bib27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2026.04.022_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","article-title":"SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI)","volume":"10","author":"Abbara","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.cgh.2026.04.022_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1148\/radiol.2017172181","article-title":"Central core laboratory versus site interpretation of coronary CT angiography: agreement and association with cardiovascular events in the PROMISE trial","volume":"287","author":"Lu","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2026.04.022_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jamacardio.2023.5661","article-title":"Effects of pitavastatin on coronary artery disease and inflammatory biomarkers in HIV: mechanistic substudy of the REPRIEVE randomized clinical trial","volume":"9","author":"Lu","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cgh.2026.04.022_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.016443","article-title":"Coronary atherosclerotic plaque burden assessment by computed tomography and its clinical implications","volume":"17","author":"Vatsa","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cgh.2026.04.022_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.04.022_bib33","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/eurjpc\/zwab120","article-title":"Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease","volume":"28","author":"Ichikawa","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cgh.2026.04.022_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131138","article-title":"Nonalcoholic hepatic steatosis is a strong predictor of high-risk coronary-artery plaques as determined by multidetector CT","volume":"10","author":"Osawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2026.04.022_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/hep4.1155","article-title":"Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis","volume":"2","author":"Zhou","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2026.04.022_bib36","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.cgh.2021.09.021","article-title":"A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease","volume":"20","author":"Toh","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.04.022_bib37","first-page":"E168","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Barton Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cgh.2026.04.022_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100366","article-title":"Intensive lipid lowering agents and coronary atherosclerosis: insights from intravascular imaging","volume":"11","author":"Di Giovanni","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.cgh.2026.04.022_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2026.04.022_bib40","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamacardio.2021.3055","article-title":"Association of Statin treatment with progression of coronary atherosclerotic plaque composition","volume":"6","author":"Van Rosendael","year":"2021","journal-title":"JAMA Cardiol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:44:16Z","timestamp":1783165456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526003265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"alternative-id":["S1542356526003265"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.04.022","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic Steatosis Is Associated With Increased Cardiovascular Risk Through Adverse Coronary Plaque Composition","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}